CORVUS PHARMACEUTICALS INC (CRVS) Stock Balance Sheet
NASDAQ:CRVS - Nasdaq - US2210151005 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 8.74M | 12.62M | 13.20M | 63.50M | 16.50M | |||
| Marketable Securities | 43.22M | 14.53M | 29.10M | 6.00M | 27.80M | |||
| Receivables | 216.00K | 63.00K | 600.00K | 500.00K | 100.00K | |||
| Other Current Assets | 2.23M | 744.00K | 700.00K | 1.30M | 1.00M | |||
| Total Current Assets | 54.41M | 27.96M | 43.70M | 71.30M | 45.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.33M | 1.39M | 2.60M | 3.60M | 2.60M | |||
| Investments And Advances | 12.54M | 16.12M | 21.90M | 34.30M | 37.20M | |||
| Other Non-Current Assets | 632.00K | 89.00K | 100.00K | 200.00K | 400.00K | |||
| Total Non-Current Assets | 14.50M | 17.60M | 24.50M | 38.20M | 40.20M | |||
| TOTAL ASSETS | 68.91M | 45.55M | 68.20M | 109.50M | 85.50M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 3.91M | 5.34M | 8.80M | 8.10M | 8.70M | |||
| Accounts Payable | 2.58M | 1.52M | 2.00M | 1.60M | 3.50M | |||
| Other Current Liabilities | 28.91M | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 35.40M | 6.87M | 10.80M | 9.70M | 12.10M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 937.00K | N/A | 1.40M | 2.60M | 1.20M | |||
| Total Non-Current Liabilities | 937.00K | 0.00 | 1.30M | 2.60M | 1.30M | |||
| TOTAL LIABILITIES | 36.34M | 6.87M | 12.10M | 12.30M | 13.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -397.01M | -334.72M | -307.70M | -266.40M | -223.10M | |||
| Additional Paid In Capital | 430.86M | 374.36M | 364.40M | 361.70M | 295.30M | |||
| Common Shares | 7.00K | 5.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -1.29M | -967.00K | -600.00K | 1.90M | 0.00 | |||
| Shares Outstanding | 67.90M | 49.04M | 46.60M | 46.60M | 28.40M | |||
| Tangible Book Value per Share | 0.48 | 0.79 | 1.20 | 2.09 | 2.54 | |||
| Total Shareholders' Equity | 32.57M | 38.68M | 56.10M | 97.20M | 72.10M | |||
| TOTAL LIABILITIES AND EQUITY | 68.91M | 45.55M | 68.20M | 109.50M | 85.50M | |||
| Statistics | ||||||||
| Current Ratio | 1.54 | 4.07 | 4.05 | 7.35 | 3.74 | |||
| Return On Assets (ROA) | -90.40% | -59.34% | -60.57% | -39.49% | -7.02% | |||
| Return On Equity (ROE) | -191.27% | -69.87% | -73.64% | -44.49% | -8.32% | |||
All data in USD , ROIC based on taxRate of 0.21